Scarica l'app Stockscreener
4.69
0.86%
0.04
Dopo l'orario di chiusura:
4.52
-0.17
-3.62%
Endra Life Sciences Inc Borsa (NDRA) Ultime notizie
ENDRA Life Sciences Inc.Common Stock (NQ: NDRA - FinancialContent
NDRA Stock Price, Quote & Chart | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
ENDRA Life Sciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView
ENDRA (NDRA) Optimistic About TAEUS Technology's Potential - GuruFocus
ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
ENDRA Life Sciences (NASDAQ: NDRA) flags going-concern risk and pivots to digital asset treasury - Stock Titan
ENDRA Life Sciences | 8-K: ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Moomoo
ENDRA Life Sciences Q4 net loss narrows - TradingView
ENDRA Life Sciences (NASDAQ: NDRA) cuts 2025 operating costs sharply - Stock Titan
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Business Wire
Day Trade: Whats the MACD signal for ENDRA Life Sciences Inc2026 Market Overview & Daily Entry Point Alerts - baoquankhu1.vn
Movement Recap: Does ENDRA Life Sciences Inc outperform in volatile marketsWeekly Market Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn
ENDRA Life Sciences (NDRA) Expected to Announce Earnings on Monday - National Today
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
NDRA Ignites: 20% Surge Signals Strategic Overhaul as Capital Hunt for Micro-Cap Alphas - Bitget
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
ENDRA Life Sciences Explores Strategic Alternatives Amid Restructuring - The Globe and Mail
ENDRA Life Sciences explores strategic alternatives By Investing.com - in.investing.com
Speculation Alert: PRSO, ITOC, NDRA, BZAI Small-Cap Momentum Builds – More Names Inside - FinancialContent
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value - BioSpace
Strategic options review launched by ENDRA Life Sciences (Nasdaq: NDRA) - Stock Titan
ENDRA Life Sciences explores strategic alternatives - Investing.com
ENDRA (NDRA) Explores Strategic Options to Enhance Shareholder V - GuruFocus
ENDRA Life Sciences Inc. Initiates Review of Strategic Alternatives to Maximize Shareholder Value - MarketScreener
ENDRA Life Sciences Inc announced that its Board of Directors has initiated a strategic review process aimed at a comprehensive assessment of the company’s future development pathways. - Bitget
ENDRA Life Sciences (NDRA) Expected to Announce Quarterly Earnings on Monday - Defense World
If You Invested $1,000 in Endra Life Sciences Inc (NDRA) - Stock Titan
Tech Rally: Is ENDRA Life Sciences Inc being accumulated by smart money2026 Patterns & Reliable Price Action Trade Plans - baoquankhu1.vn
Stocks Under $10: IBRX, VTIX, NDRA, SMX2026 Watch Now! - openPR.com
Stocks Under $10: IBRX, VTIX, NDRA, SMX – 2026 Watch Now! - The Norfolk Daily News
IBRX, VTIX, NDRA, SMX – 2026 Watch Now! - FinancialContent
ENDRA Life Sciences (NASDAQ: NDRA) - MarketScreener
ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play in the $100B+MASH+GLP-1 Healthcare Boom - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play In The $100B+MASH+GLP-1 Healthcare Boom - Mena FN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
User - The Chronicle-Journal
ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now! - Barchart.com
FinancialContentFavorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA) - FinancialContent
Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA - FinancialContent
Favorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA) - Barchart
Favorable Results on Liver Device for Long-Term Monitoring - openPR.com
Will ENDRA Life Sciences Inc. stock outperform growth indexesWeekly Trend Summary & Reliable Entry Point Alerts - Naître et grandir
[Form 4] ENDRA Life Sciences Inc. Insider Trading Activity - Stock Titan
NDRA's TAEUS system Reaches MRI-Comparable Accuracy in Liver Imaging - Bitget
NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision - TradingView
NDRA Should I Buy - Intellectia AI
NDRA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Stocks in the News: ALBT, NDRA, CURX, HCTIAI, Clinical Milestones Drive Market Surges - marketscreener.com
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Le - PharmiWeb.com
Endra Life Sciences (NDRA) Announces Positive Trial Results for Liver Device - GuruFocus
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care - Yahoo Finance
Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now! - openPR.com
0.17%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):